Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Arctic Therapeutics ehf.
Sponsor

Arctic Therapeutics ehf.

Iceland Bjargargata 1, 102 Reykjavik, Iceland

About the sponsor

Arctic Therapeutics hf. supports clinical research in acne vulgaris, with interest in topical treatment approaches that address inflammatory and non-inflammatory skin lesions, as well as clinical assessment of visible disease improvement.

  • Acne vulgaris
  • Topical therapy
  • Inflammatory lesions
  • Non-inflammatory lesions

Its dermatology portfolio centers on treatment evaluation in adult patients with active facial and truncal skin disease.

About Specializations

Arctic Therapeutics ehf. runs clinical trials in conditions such as Cerebral amyloid angiopathy, Acne, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Cerebral amyloid angiopathy

Not yet recruiting

Study on the Safety and Effects of Acetylcysteine Amide for Patients Aged 12 and Over with Hereditary Cystatin C Amyloid Angiopathy

InvestigationalNo placebo
Countries:IcelandIceland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Acetylcysteine Amide
  • Sponsor:Arctic Therapeutics ehf.

Acne

Not recruiting

Study of Topical Donepezil Hydrochloride Cream for Safety and Effectiveness in Adult Patients with Acne Vulgaris

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Donepezil Hydrochloride
  • Sponsor:Arctic Therapeutics ehf.

Study on the Safety and Effects of NPI-001 (Acetylcysteine Amide) for Patients Aged 50-85 with Mild Cognitive Impairment or Mild Alzheimer's Disease

Not recruiting
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acetylcysteine Amide
  • Sponsor:Arctic Therapeutics ehf.

Cerebral amyloid angiopathy

Not recruiting

Study on the Safety and Effects of Acetylcysteine Amide for Patients Aged 12 and Over with Hereditary Cystatin C Amyloid Angiopathy

InvestigationalNo placebo
Countries:IcelandIceland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Acetylcysteine Amide
  • Sponsor:Arctic Therapeutics ehf.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.